NEW! ...VS A1/Androstadienone MX412

It’s tough though John, innovation is harder with rolling black outs. It just seems like (I know it’s not you or AD’s fault) that everytime we come up with something great, components are out of stock. I remember that there are rare ones, and ones so much more common. I do know that it would be near impossible to guarantee it but if we could get an idea what molecules would be easier to keep in stock i.e. track record for the chemist in producing the molecules in a timely matter, cost effectiveness, and reproductability would help move the research forward because if we know what we can work with on a consistent basis, then you wouldn’t have so many things go to waste because it’s missing a molecule that’s going to take months to come back.